BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 32311088)

  • 1. Deficit of circulating CD19
    Zaimoku Y; Patel BA; Kajigaya S; Feng X; Alemu L; Quinones Raffo D; Groarke EM; Young NS
    Br J Haematol; 2020 Aug; 190(4):610-617. PubMed ID: 32311088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic obstructive pulmonary disease is characterized by reduced levels and defective suppressive function of regulatory B cells in peripheral blood.
    Lin S; Ma Z; Huang Y; Sun Y; Yi H
    Mol Immunol; 2022 Jan; 141():87-93. PubMed ID: 34837778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1
    Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A
    Front Immunol; 2018; 9():2241. PubMed ID: 30327652
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19
    Zhang Y; Wei S; Wu Q; Shen X; Dai W; Zhang Z; Chen M; Huang H; Ma L
    Clin Rheumatol; 2022 Aug; 41(8):2403-2416. PubMed ID: 35420296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies.
    Aybar LT; McGregor JG; Hogan SL; Hu Y; Mendoza CE; Brant EJ; Poulton CJ; Henderson CD; Falk RJ; Bunch DO
    Clin Exp Immunol; 2015 May; 180(2):178-88. PubMed ID: 25376552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD24
    Xu C; Zhang M; Li K; Ni M; Bai Y; Zhang J; Song X; Wang J
    Int Immunopharmacol; 2019 May; 70():295-301. PubMed ID: 30851710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
    Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
    Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased number of CD19
    Li T; Yu Z; Qu Z; Zhang N; Crew R; Jiang Y
    Mol Immunol; 2019 Aug; 112():233-239. PubMed ID: 31181422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation.
    Flores-Borja F; Bosma A; Ng D; Reddy V; Ehrenstein MR; Isenberg DA; Mauri C
    Sci Transl Med; 2013 Feb; 5(173):173ra23. PubMed ID: 23427243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD19
    Chen Q; Lai L; Chi X; Lu X; Wu H; Sun J; Wu W; Cai L; Zeng X; Wang C; Chen W; Peng A
    Mediators Inflamm; 2020; 2020():3019378. PubMed ID: 32104147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease in the proportion of CD24
    Wang Y; Qin Y; Wang X; Zhang L; Wang J; Xu X; Chen H; Hsu HT; Zhang M
    Clin Exp Immunol; 2020 Apr; 200(1):22-32. PubMed ID: 31849037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory B cells (CD19(+)CD38(hi)CD24(hi)) in alloimmunized and non-alloimmunized children with β-thalassemia major.
    Zahran AM; Elsayh KI; Saad K; Embaby M; Ali AM
    Blood Cells Mol Dis; 2016 Mar; 57():91-6. PubMed ID: 26852663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The correlation of CD19 + CD24 + CD38 + B cells and other clinicopathological variables with the proportion of circulating Tregs in breast cancer patients.
    Gheybi MK; Farrokhi S; Ravanbod MR; Ostovar A; Mehrzad V; Nematollahi P
    Breast Cancer; 2017 Nov; 24(6):756-764. PubMed ID: 28429331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD24
    Hasan MM; Thompson-Snipes L; Klintmalm G; Demetris AJ; O'Leary J; Oh S; Joo H
    J Immunol; 2019 Oct; 203(8):2110-2120. PubMed ID: 31511354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and Immunophenotypic Characterization of Human CD19
    Bradford HF; Mauri C
    Methods Mol Biol; 2021; 2270():77-90. PubMed ID: 33479894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of CD19
    Zhao Q; Jung LK
    Pediatr Rheumatol Online J; 2018 Jul; 16(1):44. PubMed ID: 29973221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired function of CD19(+) CD24(hi) CD38(hi) regulatory B cells in patients with pemphigus.
    Zhu HQ; Xu RC; Chen YY; Yuan HJ; Cao H; Zhao XQ; Zheng J; Wang Y; Pan M
    Br J Dermatol; 2015 Jan; 172(1):101-10. PubMed ID: 24935080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD.
    Khoder A; Sarvaria A; Alsuliman A; Chew C; Sekine T; Cooper N; Mielke S; de Lavallade H; Muftuoglu M; Fernandez Curbelo I; Liu E; Muraro PA; Alousi A; Stringaris K; Parmar S; Shah N; Shaim H; Yvon E; Molldrem J; Rouce R; Champlin R; McNiece I; Mauri C; Shpall EJ; Rezvani K
    Blood; 2014 Sep; 124(13):2034-45. PubMed ID: 25051962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.
    Townsley DM; Scheinberg P; Winkler T; Desmond R; Dumitriu B; Rios O; Weinstein B; Valdez J; Lotter J; Feng X; Desierto M; Leuva H; Bevans M; Wu C; Larochelle A; Calvo KR; Dunbar CE; Young NS
    N Engl J Med; 2017 Apr; 376(16):1540-1550. PubMed ID: 28423296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.
    Blair PA; Noreña LY; Flores-Borja F; Rawlings DJ; Isenberg DA; Ehrenstein MR; Mauri C
    Immunity; 2010 Jan; 32(1):129-40. PubMed ID: 20079667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.